Chicago Capital’s ResMed RMD Stock Holding History

Chicago Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.18M	Hold	14,363	–	–	0.07%	113
2026 Q2	$2.8M	Hold	14,363	–	–	0.07%	123
2026 Q1	$3.22M	Sell	14,363 -1,226	-8%	-$306K	0.09%	110
2025 Q4	$3.75M	Buy	15,589 +108	+0.7%	+$27.6K	0.09%	96
2025 Q3	$4.24M	Sell	15,481 -2,541	-14%	-$694K	0.1%	92
2025 Q2	$4.65M	Sell	18,022 -40	-0.2%	-$9.5K	0.11%	89
2025 Q1	$4.04M	Sell	18,062 -189	-1%	-$44.1K	0.11%	92
2024 Q4	$4.17M	Buy	18,251 +3,551	+24%	+$855K	0.11%	90
2024 Q3	$3.59M	Hold	14,700	–	–	0.1%	96
2024 Q2	$2.81M	Buy	14,700 +12,500	+568%	+$2.54M	0.08%	104
2024 Q1	$436K	Buy	+2,200	New	+$403K	0.01%	229

Other funds holding RMD

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Chicago Capital's RMD Position: Q3 2026 in Review

Chicago Capital held its ResMed (RMD) position steady in Q3 2026 at 14,363 shares worth $3.18M. The position accounts for 0.07% of the portfolio, ranked #113.

Chicago Capital first reported a position in RMD in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.65M in Q2 2025. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Chicago Capital held 14,363 shares of ResMed worth $3.18M as of Q3 2026.
Chicago Capital left its ResMed share count unchanged in Q3 2026.
ResMed made up 0.07% of Chicago Capital's portfolio in Q3 2026, its #113 holding.
Chicago Capital first reported a position in ResMed in Q1 2024 and has held it in 11 quarters since.
Chicago Capital's ResMed position peaked at $4.65M in Q2 2025.
741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Chicago Capital's 13F filing for Q3 2026, filed 13 Oct 2026.